跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
LEVETIRACETAM-LAPL levetiracetam 500 mg tablet blister pack
Approved
STANDARD
LEVETIRACETAM-LAPL levetiracetam 500 mg tablet blister pack
Lupin Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
3b6454dc96f72611
Company
Lupin Australia Pty Limited
Type
Standard
Approval Details
Approval Id
3b6454dc96f72611
Product Name
LEVETIRACETAM-LAPL levetiracetam 500 mg tablet blister pack
Artg Id
161289
Artg Name
LEVETIRACETAM-LAPL levetiracetam 500 mg tablet blister pack
Sponsor
Lupin Australia Pty Limited
Company Detail Path
/organization/lupin-australia-pty-limited
Artg Date
2010-07-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/dba7e12fca53619d8f6d81021e114f5f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
3b6454dc96f72611
Type
Standard
Back to TGA Approvals
LEVETIRACETAM-LAPL levetiracetam 500 mg tablet blister pack - TGA Drug Approval Details